These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 23867826)
41. Upregulation of microRNA-492 induced by epigenetic drug treatment inhibits the malignant phenotype of clear cell renal cell carcinoma in vitro. Wu A; Wu K; Li M; Bao L; Shen X; Li S; Li J; Yang Z Mol Med Rep; 2015 Jul; 12(1):1413-20. PubMed ID: 25815441 [TBL] [Abstract][Full Text] [Related]
42. Screening biomarkers of bladder cancer using combined miRNA and mRNA microarray analysis. Jin N; Jin X; Gu X; Na W; Zhang M; Zhao R Mol Med Rep; 2015 Aug; 12(2):3170-6. PubMed ID: 25955758 [TBL] [Abstract][Full Text] [Related]
43. Functional analyses and prognostic significance of SFRP1 expression in bladder cancer. Rogler A; Kendziorra E; Giedl J; Stoehr C; Taubert H; Goebell PJ; Wullich B; Stöckle M; Lehmann J; Petsch S; Hartmann A; Stoehr R J Cancer Res Clin Oncol; 2015 Oct; 141(10):1779-90. PubMed ID: 25732201 [TBL] [Abstract][Full Text] [Related]
44. Expression Level of Urinary MicroRNA-146a-5p Is Increased in Patients With Bladder Cancer and Decreased in Those After Transurethral Resection. Sasaki H; Yoshiike M; Nozawa S; Usuba W; Katsuoka Y; Aida K; Kitajima K; Kudo H; Hoshikawa M; Yoshioka Y; Kosaka N; Ochiya T; Chikaraishi T Clin Genitourin Cancer; 2016 Oct; 14(5):e493-e499. PubMed ID: 27157639 [TBL] [Abstract][Full Text] [Related]
45. Involvement of epigenetics and EMT-related miRNA in arsenic-induced neoplastic transformation and their potential clinical use. Michailidi C; Hayashi M; Datta S; Sen T; Zenner K; Oladeru O; Brait M; Izumchenko E; Baras A; VandenBussche C; Argos M; Bivalacqua TJ; Ahsan H; Hahn NM; Netto GJ; Sidransky D; Hoque MO Cancer Prev Res (Phila); 2015 Mar; 8(3):208-21. PubMed ID: 25586904 [TBL] [Abstract][Full Text] [Related]
46. Higher Expression of miR-182 in Cytology Specimens of High-Grade Urothelial Cell Carcinoma: A Potential Diagnostic Marker. Wei S; Bing Z; Yao Y; Master SR; Gupta P Acta Cytol; 2015; 59(1):109-12. PubMed ID: 25676538 [TBL] [Abstract][Full Text] [Related]
47. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection. Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885 [TBL] [Abstract][Full Text] [Related]
48. Micro RNA expression and prognosis in low-grade non-invasive urothelial carcinoma. Dip N; Reis ST; Abe DK; Viana NI; Morais DR; Moura CM; Katz B; Silva IA; Srougi M; Leite KR Int Braz J Urol; 2014; 40(5):644-9. PubMed ID: 25498275 [TBL] [Abstract][Full Text] [Related]
49. Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer. Dudziec E; Miah S; Choudhry HM; Owen HC; Blizard S; Glover M; Hamdy FC; Catto JW Clin Cancer Res; 2011 Mar; 17(6):1287-96. PubMed ID: 21138856 [TBL] [Abstract][Full Text] [Related]
50. microRNA-145 promotes differentiation in human urothelial carcinoma through down-regulation of syndecan-1. Fujii T; Shimada K; Tatsumi Y; Hatakeyama K; Obayashi C; Fujimoto K; Konishi N BMC Cancer; 2015 Oct; 15():818. PubMed ID: 26514209 [TBL] [Abstract][Full Text] [Related]
51. The relationship between DNA methyltransferase 3B (DNMT3B) and miR 124-3pa expressions in bladder cancer tissues. Fawzy MS; El Faiomy ARM; El Desoky AMZ; Hussein S Mol Biol Rep; 2023 Dec; 50(12):10005-10013. PubMed ID: 37902910 [TBL] [Abstract][Full Text] [Related]
52. Network Biomarkers of Bladder Cancer Based on a Genome-Wide Genetic and Epigenetic Network Derived from Next-Generation Sequencing Data. Li CW; Chen BS Dis Markers; 2016; 2016():4149608. PubMed ID: 27034531 [TBL] [Abstract][Full Text] [Related]
53. MicroRNA signatures in human ovarian cancer. Iorio MV; Visone R; Di Leva G; Donati V; Petrocca F; Casalini P; Taccioli C; Volinia S; Liu CG; Alder H; Calin GA; Ménard S; Croce CM Cancer Res; 2007 Sep; 67(18):8699-707. PubMed ID: 17875710 [TBL] [Abstract][Full Text] [Related]
54. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers. Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Kazubskaya TP; Dmitriev AA; Braga EA Gene; 2016 Jan; 576(1 Pt 3):483-91. PubMed ID: 26519551 [TBL] [Abstract][Full Text] [Related]
55. Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer. Saini S; Arora S; Majid S; Shahryari V; Chen Y; Deng G; Yamamura S; Ueno K; Dahiya R Cancer Prev Res (Phila); 2011 Oct; 4(10):1698-709. PubMed ID: 21836020 [TBL] [Abstract][Full Text] [Related]
56. Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary Diseases. Ohtsubo K; Miyake K; Arai S; Fukuda K; Yanagimura N; Suzuki C; Otani S; Adachi Y; Tanimoto A; Nishiyama A; Yamashita K; Takeuchi S; Notohara K; Yoshimura K; Yano S Anticancer Res; 2019 Oct; 39(10):5449-5459. PubMed ID: 31570439 [TBL] [Abstract][Full Text] [Related]
57. Insights into epigenetic regulation of microRNA-155 expression in multiple myeloma. Krzeminski P; Sarasquete ME; Misiewicz-Krzeminska I; Corral R; Corchete LA; Martín AA; García-Sanz R; San Miguel JF; Gutiérrez NC Biochim Biophys Acta; 2015 Mar; 1849(3):353-66. PubMed ID: 25497370 [TBL] [Abstract][Full Text] [Related]
58. Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells. Jou YC; Wang SC; Dai YC; Chen SY; Shen CH; Lee YR; Chen LC; Liu YW Oncol Rep; 2019 Sep; 42(3):1005-1016. PubMed ID: 31322264 [TBL] [Abstract][Full Text] [Related]
59. Global epigenetic regulation of microRNAs in multiple myeloma. Zhang W; Wang YE; Zhang Y; Leleu X; Reagan M; Zhang Y; Mishima Y; Glavey S; Manier S; Sacco A; Jiang B; Roccaro AM; Ghobrial IM PLoS One; 2014; 9(10):e110973. PubMed ID: 25330074 [TBL] [Abstract][Full Text] [Related]
60. A DNA hypermethylation profile reveals new potential biomarkers for the evaluation of prognosis in urothelial bladder cancer. López JI; Angulo JC; Martín A; Sánchez-Chapado M; González-Corpas A; Colás B; Ropero S APMIS; 2017 Sep; 125(9):787-796. PubMed ID: 28586118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]